First Time Us Pharmaceuticals (India) Private Limited - Company Profile

It is a healthcare foreign private limited company based in Navi Mumbai, Maharashtra, India, established in 2013.
2013 Navi Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About First Time Us Pharmaceuticals (India) Private Limited

First Time Us Pharmaceuticals (India) Private Limited, a active foreign private limited company, was established on 10 June 2013 in Navi Mumbai, Maharashtra, India. Engaging in medical equipment retail & distribution within the professional, scientific and technical sector, it holds CIN: U74999MH2013FTC244256. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.37 Cr.

It upholds a compliant status. Employing 48 professional, Its leadership includes Vibhor Shirish Misar (Director), Manesh Ashok Dixit (Director), Sachin Janardan Bhusari (Nominee Director). Past directors included Vibhor Shirish Misar, Priyanka Shirishkumar Misar, Ashok Arjun Mhaske. Its latest AGM occurred on 30 October 2025, with the balance sheet filed on 31 March 2025. It is based at C-112, Pawane, T.T.C Industrial Area, M.I.D.C.,, Navi Mumbai, Maharashtra, 400705.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2013FTC244256

  • Registration Number

    244256

  • Incorporation Date

    10 June 2013

  • Authorized Capital

    ₹6.00 Cr

  • Paid-Up Capital

    ₹4.37 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.00 Cr
  • Paid Up Capital ₹ 4.37 Cr
  • Company Age 12 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 42.57%
  • Profit Growth **** 661.23%
  • Ebitda **** 352.14%
  • Net Worth 29.01%
  • Total Assets **** 39.46%
Company report

First Time Us Pharmaceuticals (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into First Time Us Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at First Time Us Pharmaceuticals (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Vibhor Shirish Misar Director 18 Dec 2013 Current
Manesh Ashok Dixit Director 10 Jun 2013 Current
Sachin Janardan Bhusari Nominee Director 13 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2014 Past
Pramod Abcsdd Director 29 Jul 2025 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of First Time Us Pharmaceuticals (India).

First Time Us Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.57% increase. The company also saw a substantial improvement in profitability, with a 661.23% increase in profit. The company's net worth Soared by an impressive increase of 29.01%.

First Time Us Pharmaceuticals (India) revenue growth over time
First Time Us Pharmaceuticals (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 42.57%
*******
*******
*******
*******
Revenue from Operations
*******
 45.22%
*******
*******
*******
*******
Total Assets
*******
 39.46%
*******
*******
*******
*******
Profit or Loss
*******
 661.23%
*******
*******
*******
*******
Net Worth
*******
 29.01%
*******
*******
*******
*******
EBITDA
*******
 352.14%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of First Time Us Pharmaceuticals (India)?

In 2023, First Time Us Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at First Time Us Pharmaceuticals (India)?

First Time Us Pharmaceuticals (India) has a workforce of 48 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of First Time Us Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped First Time Us Pharmaceuticals (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on First Time Us Pharmaceuticals (India)
Recent Activity within the Organization
  • Annual General Meeting

    The activity First Time Us Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Oct 2025 as per latest MCA records. was completed.

  • Director Appointment

    The activity Sachin Janardan Bhusari was appointed as a Nominee Director was appointed as a Nominee Director on 13 Aug 2025 & has been associated with this company since 6 months 5 days . was completed.

  • Balance Sheet

    Progress on First Time Us Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Vibhor Shirish Misar was appointed as a Director was appointed as a Director on 18 Dec 2013 & has been associated with this company since 12 years 2 months . was recorded as a recent event.

  • Director Appointment

    Manesh Ashok Dixit was appointed as a Director was appointed as a Director on 10 Jun 2013 & has been associated with this company since 12 years 8 months . was recorded as a recent event.

  • Company Incorporation

    Progress on First Time Us Pharmaceuticals (India) Private Limited was registered on 10 Jun 2013 with Roc Mumbai & aged 12 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of First Time Us Pharmaceuticals (India) Private Limited?

The CIN of First Time Us Pharmaceuticals (India) Private Limited is U74999MH2013FTC244256.

Where is First Time Us Pharmaceuticals (India) Private Limited headquartered?

First Time Us Pharmaceuticals (India) Private Limited is headquartered at C-112, Pawane, T.T.C Industrial Area, M.I.D.C.,, Navi Mumbai, Maharashtra, 400705.

When was First Time Us Pharmaceuticals (India) Private Limited incorporated?

First Time Us Pharmaceuticals (India) Private Limited was incorporated on 10 June 2013.

Who are the current directors of First Time Us Pharmaceuticals (India) Private Limited?

The current directors of First Time Us Pharmaceuticals (India) Private Limited are

What is the primary industry of First Time Us Pharmaceuticals (India) Private Limited?

The primary industry of First Time Us Pharmaceuticals (India) Private Limited is Professional, Scientific And Technical.

Is First Time Us Pharmaceuticals (India) Private Limited a listed company?

First Time Us Pharmaceuticals (India) Private Limited is unlisted.

What is the capital structure of First Time Us Pharmaceuticals (India) Private Limited?

The authorized capital of First Time Us Pharmaceuticals (India) Private Limited is ₹6.00 Cr, and the paid-up capital is ₹4.37 Cr.

What is the compliance status of First Time Us Pharmaceuticals (India) Private Limited?

The compliance status of First Time Us Pharmaceuticals (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available